DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Track the Success of New Products with Emerging Therapies

Understand how adoption, trial, and usage of new products affect on market dynamics.

  • Anticipate the potential impact on current brand to inform product launch strategies
  • Track physicians’ adoption of and attitudes toward newly launched brands, benchmarked against comparable past launches
  • Determine which factors drive product awareness and how you might optimize your strategies to protect market share or maximize the impact of new product launches.

Insights into positioning, threat, and potential of emerging drugs and tracking of recently launched brands.

Emerging Therapies analyzes the performance and impact of newly launched drugs in key indications:

  • Sequential surveys of 100 physician specialists at 1, 3, 6 and 12 months post-launch
  • Each wave includes qualitative insights from 15 in-depth interviews

Learn More